CareLit · DOI-Nachweis · Aktuelle Neurologie
In vivo amyloid imaging with the new radiotracer [N-Methyl-11C]2-(4'-(methylamino)phenyl)-benzothiazol (C-11-BTA-1) in Alzheimer's disease
DOI 10.1055/s-2006-953009
Bibliografische Angaben
Nachweis in CareLit
Autor:innenC.A.F. von Arnim, K. Gerhard, S. Thees, S. Deisenhofer, B. Neumaier, I. Uttner, A.C. Ludolph, S.N. Reske, F.M. Mottaghy
ZeitschriftAktuelle Neurologie
Ausgabe09/2006
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Aims: Over the last years there has been great effort to develop novel in vivo amyloid-imaging radiotracers for use with positron emission tomography (PET) to allow noninvasive in vivo assessments of amyloid plaques. This might lead to a better understanding of amyloid deposition over the course of disease in Alzheimer's disease (AD), and might eventually provide a surrogate marker of potential antiamyloid therapies…
Zitieren
Zitierempfehlung
C.A.F. von Arnim, K. Gerhard, S. Thees, S. Deisenhofer, B. Neumaier, I. Uttner, A.C. Ludolph, S.N. Reske, F.M. Mottaghy (2006) In vivo amyloid imaging with the new radiotracer [N-Methyl-11C]2-(4'-(methylamino)phenyl)-benzothiazol (C-11-BTA-1) in Alzheimer's disease. Aktuelle Neurologie (09). https://doi.org/10.1055/s-2006-953009
Mit CareLit weiterarbeiten